Want to see VRPX full AI Analyst Report?
Virpax Pharmaceuticals (VRPX) Financial Statements
Virpax Pharmaceuticals Financial Overview
Virpax Pharmaceuticals's market cap is currently $994. The company's EPS TTM is $-5.73; its P/E ratio is 0.00; Virpax Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 24 | Dec 23 | Dec 22 | Mar 22 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -12.08M | $ -15.69M | $ -21.85M | $ -12.03M | $ -4.20M |
| EBITDA | $ -11.96M | $ -2.25M | $ -3.31M | $ 62.26K | $ 4.00K |
| Net Income | $ -12.07M | $ -15.19M | $ -21.46M | $ -12.15M | $ -4.49M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.51M | $ 9.14M | $ 19.00M | $ 36.84M | $ 54.80K |
| Total Assets | $ 1.56M | $ 9.63M | $ 19.67M | $ 39.57M | $ 465.41K |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 1.57M |
| Net Debt | $ -1.51M | $ -9.14M | $ -19.00M | $ -36.84M | $ 1.51M |
| Total Liabilities | $ 2.47M | $ 7.69M | $ 3.09M | $ 2.09M | $ 4.68M |
| Stockholders' Equity | $ -913.76K | $ 1.93M | $ 16.58M | $ 37.48M | $ -4.22M |
| Cash Flow | |||||
| Free Cash Flow | $ -16.71B | $ -9.85M | $ -17.85M | $ -14.54M | $ -1.38M |
| Operating Cash Flow | $ -16.71B | $ -9.85M | $ -17.85M | $ -14.54M | $ -1.38M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 9.08B | $ 0.00 | $ 0.00 | $ 51.33M | $ 1.40M |
Currency in USD